Two Million Stillbirths Occur Annually; Pandemic Add To Risks In Coming Year, Says First UN Report On The Neglected Issue 08/10/2020 Madeleine Hoecklin One stillbirth occurs every 16 seconds worldwide with approximately 2 million stillborn babies a year, says the first UN-wide report to document the global scale of the issue. And COVID-19 related interruptions in maternal and child care services, particularly emergency obstetric care, could lead to an additional 60,000 to 200,000 stillbirths over the next 12 […] Continue reading -> Avoiding An ‘Airpocalypse’ – Delhi Declares War on Air Pollution 07/10/2020 Jyoti Pande Lavakare With fires from crop stubble burning spreading across northern India heralding the beginning of Delhi’s winter air pollution season, Delhi’s Chief Minister Arvind Kejriwal has pledged to take pre-emptive action – announcing a ‘war on pollution,’ led from a ‘war room’ that he will personally command. His arsenal includes a seven-point action plan that will […] Continue reading -> Over 90% Of The World’s Countries Report Disruptions Of Critical Mental Health Services – WHO Survey 05/10/2020 Svĕt Lustig Vijay The COVID-19 pandemic has disrupted mental health services in 93% of countries at a time when they are most needed, concludes a new WHO survey, released Monday. The survey is based on data from 130 WHO countries gathered between June and August 2020. Despite rising awareness of the enormous strain that the pandemic has placed […] Continue reading -> Geneva’s International Chamber Of Commerce Hosts Dialogue Involving Geneva UN Agency and Big Tobacco – For Second Year In A Row 01/10/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher For the second year in a row, Geneva’s International Chamber of Commerce has hosted a dialogue bringing local tobacco industry leaders together with a major Geneva-based UN Agency – in this case to discuss the ‘role of multinationals in economic recovery following the coronavirus’. The ICC’s 6th Business Dialogue, involving Teresa Moreira, Head Competition and […] Continue reading -> World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> Most Countries Still Have ‘Long Way To Go’ On Tobacco Control In Public Places & Taxation 29/09/2020 Svĕt Lustig Vijay As fresh data reveals that tobacco products kill over 2 million people a year through coronary heart disease, tobacco control advocates are more determined than ever to protect the world against a product that kills half its users, not only from heart attacks but stroke, lung cancer and other diseases as well. Comprehensive, but simple […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> Global Aid, Local Choice – Why Calls For Transparency Cut Both Ways 28/09/2020 Ize Adava When donor dollars go missing, the guilty must be held to account. But when past transgressions hold country-ownership of global health programs to ransom with no clear end in sight, everyone loses. Today, almost two million people are living with HIV in Nigeria yet the latest UNAIDS figures show that only about one out of every […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Avoiding An ‘Airpocalypse’ – Delhi Declares War on Air Pollution 07/10/2020 Jyoti Pande Lavakare With fires from crop stubble burning spreading across northern India heralding the beginning of Delhi’s winter air pollution season, Delhi’s Chief Minister Arvind Kejriwal has pledged to take pre-emptive action – announcing a ‘war on pollution,’ led from a ‘war room’ that he will personally command. His arsenal includes a seven-point action plan that will […] Continue reading -> Over 90% Of The World’s Countries Report Disruptions Of Critical Mental Health Services – WHO Survey 05/10/2020 Svĕt Lustig Vijay The COVID-19 pandemic has disrupted mental health services in 93% of countries at a time when they are most needed, concludes a new WHO survey, released Monday. The survey is based on data from 130 WHO countries gathered between June and August 2020. Despite rising awareness of the enormous strain that the pandemic has placed […] Continue reading -> Geneva’s International Chamber Of Commerce Hosts Dialogue Involving Geneva UN Agency and Big Tobacco – For Second Year In A Row 01/10/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher For the second year in a row, Geneva’s International Chamber of Commerce has hosted a dialogue bringing local tobacco industry leaders together with a major Geneva-based UN Agency – in this case to discuss the ‘role of multinationals in economic recovery following the coronavirus’. The ICC’s 6th Business Dialogue, involving Teresa Moreira, Head Competition and […] Continue reading -> World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> Most Countries Still Have ‘Long Way To Go’ On Tobacco Control In Public Places & Taxation 29/09/2020 Svĕt Lustig Vijay As fresh data reveals that tobacco products kill over 2 million people a year through coronary heart disease, tobacco control advocates are more determined than ever to protect the world against a product that kills half its users, not only from heart attacks but stroke, lung cancer and other diseases as well. Comprehensive, but simple […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> Global Aid, Local Choice – Why Calls For Transparency Cut Both Ways 28/09/2020 Ize Adava When donor dollars go missing, the guilty must be held to account. But when past transgressions hold country-ownership of global health programs to ransom with no clear end in sight, everyone loses. Today, almost two million people are living with HIV in Nigeria yet the latest UNAIDS figures show that only about one out of every […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Over 90% Of The World’s Countries Report Disruptions Of Critical Mental Health Services – WHO Survey 05/10/2020 Svĕt Lustig Vijay The COVID-19 pandemic has disrupted mental health services in 93% of countries at a time when they are most needed, concludes a new WHO survey, released Monday. The survey is based on data from 130 WHO countries gathered between June and August 2020. Despite rising awareness of the enormous strain that the pandemic has placed […] Continue reading -> Geneva’s International Chamber Of Commerce Hosts Dialogue Involving Geneva UN Agency and Big Tobacco – For Second Year In A Row 01/10/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher For the second year in a row, Geneva’s International Chamber of Commerce has hosted a dialogue bringing local tobacco industry leaders together with a major Geneva-based UN Agency – in this case to discuss the ‘role of multinationals in economic recovery following the coronavirus’. The ICC’s 6th Business Dialogue, involving Teresa Moreira, Head Competition and […] Continue reading -> World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> Most Countries Still Have ‘Long Way To Go’ On Tobacco Control In Public Places & Taxation 29/09/2020 Svĕt Lustig Vijay As fresh data reveals that tobacco products kill over 2 million people a year through coronary heart disease, tobacco control advocates are more determined than ever to protect the world against a product that kills half its users, not only from heart attacks but stroke, lung cancer and other diseases as well. Comprehensive, but simple […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> Global Aid, Local Choice – Why Calls For Transparency Cut Both Ways 28/09/2020 Ize Adava When donor dollars go missing, the guilty must be held to account. But when past transgressions hold country-ownership of global health programs to ransom with no clear end in sight, everyone loses. Today, almost two million people are living with HIV in Nigeria yet the latest UNAIDS figures show that only about one out of every […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Geneva’s International Chamber Of Commerce Hosts Dialogue Involving Geneva UN Agency and Big Tobacco – For Second Year In A Row 01/10/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher For the second year in a row, Geneva’s International Chamber of Commerce has hosted a dialogue bringing local tobacco industry leaders together with a major Geneva-based UN Agency – in this case to discuss the ‘role of multinationals in economic recovery following the coronavirus’. The ICC’s 6th Business Dialogue, involving Teresa Moreira, Head Competition and […] Continue reading -> World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> Most Countries Still Have ‘Long Way To Go’ On Tobacco Control In Public Places & Taxation 29/09/2020 Svĕt Lustig Vijay As fresh data reveals that tobacco products kill over 2 million people a year through coronary heart disease, tobacco control advocates are more determined than ever to protect the world against a product that kills half its users, not only from heart attacks but stroke, lung cancer and other diseases as well. Comprehensive, but simple […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> Global Aid, Local Choice – Why Calls For Transparency Cut Both Ways 28/09/2020 Ize Adava When donor dollars go missing, the guilty must be held to account. But when past transgressions hold country-ownership of global health programs to ransom with no clear end in sight, everyone loses. Today, almost two million people are living with HIV in Nigeria yet the latest UNAIDS figures show that only about one out of every […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Bank Unleashes US$12 Billion in “Fast-Track” Finance For COVID-19 Vaccine Purchases By Low- And Middle-Income Countries 30/09/2020 Elaine Ruth Fletcher The World Bank will make available up to $12 billion in “fast-track financing” that low- and middle-income countries can access to procure vaccines against Covid-19 – as soon as one is approved, said the Bank’s president David Malpass, on Wednesday. The announcement at a United Nations high-level panel on the pandemic that also included commitments […] Continue reading -> Most Countries Still Have ‘Long Way To Go’ On Tobacco Control In Public Places & Taxation 29/09/2020 Svĕt Lustig Vijay As fresh data reveals that tobacco products kill over 2 million people a year through coronary heart disease, tobacco control advocates are more determined than ever to protect the world against a product that kills half its users, not only from heart attacks but stroke, lung cancer and other diseases as well. Comprehensive, but simple […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> Global Aid, Local Choice – Why Calls For Transparency Cut Both Ways 28/09/2020 Ize Adava When donor dollars go missing, the guilty must be held to account. But when past transgressions hold country-ownership of global health programs to ransom with no clear end in sight, everyone loses. Today, almost two million people are living with HIV in Nigeria yet the latest UNAIDS figures show that only about one out of every […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Most Countries Still Have ‘Long Way To Go’ On Tobacco Control In Public Places & Taxation 29/09/2020 Svĕt Lustig Vijay As fresh data reveals that tobacco products kill over 2 million people a year through coronary heart disease, tobacco control advocates are more determined than ever to protect the world against a product that kills half its users, not only from heart attacks but stroke, lung cancer and other diseases as well. Comprehensive, but simple […] Continue reading -> WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> Global Aid, Local Choice – Why Calls For Transparency Cut Both Ways 28/09/2020 Ize Adava When donor dollars go missing, the guilty must be held to account. But when past transgressions hold country-ownership of global health programs to ransom with no clear end in sight, everyone loses. Today, almost two million people are living with HIV in Nigeria yet the latest UNAIDS figures show that only about one out of every […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO, The Pandemic And Europe’s New Global Health Leadership Role 29/09/2020 Elaine Ruth Fletcher Billions of dollars in vaccine investments are needed to beat back Covid-19. But on the bright side, Europe is playing a more active global health leadership role. Geneva’s ‘dean’ of global health speaks to Geneva Solutions ahead of Wednesday’s opening of the European Health Forum (Gastein), which brings together key policymakers and experts from across […] Continue reading -> Global Aid, Local Choice – Why Calls For Transparency Cut Both Ways 28/09/2020 Ize Adava When donor dollars go missing, the guilty must be held to account. But when past transgressions hold country-ownership of global health programs to ransom with no clear end in sight, everyone loses. Today, almost two million people are living with HIV in Nigeria yet the latest UNAIDS figures show that only about one out of every […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Aid, Local Choice – Why Calls For Transparency Cut Both Ways 28/09/2020 Ize Adava When donor dollars go missing, the guilty must be held to account. But when past transgressions hold country-ownership of global health programs to ransom with no clear end in sight, everyone loses. Today, almost two million people are living with HIV in Nigeria yet the latest UNAIDS figures show that only about one out of every […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Coronavirus Reinfection – Can You Really Get It Again? The Impacts For A Second Wave & Vaccine Development 27/08/2020 Svĕt Lustig Vijay This Tuesday, European researchers documented two new cases of COVID-19 reinfection, just a day after the first genetically proven case of reinfection was reported in a 33-year old man in Hong Kong. The 33-year old had contracted two genetically distinct strains of Covid-19 over a period of four and a half months. The potential for […] Continue reading -> Posts navigation Older postsNewer posts